Allergan fell $2.36 or 2.3 percent, to $100.46. Baxter International Inc. fell$. 05 or. 1 percent, to $70.50. Johnson& Johnson fell$. 38 or. 4 percent, to $87.26.
Allergan fell$. 96 or. 9 percent, to $102.82. Baxter International Inc. rose$. 06 or. 1 percent, to $70.55. Boston Scientific Corp. rose$. 40 or 4.6 percent, to $9.10.
Allergan rose$. 11 or. 1 percent, to $103.89. Baxter International Inc. rose$. 02 or percent, to $70.51. Boston Scientific Corp. rose$. 30 or 3.4 percent, to $9.00.
Allergan fell$. 56 or. 5 percent, to $103.22. Baxter International Inc. fell$. 03 or percent, to $70.46. Boston Scientific Corp. rose$. 20 or 2.3 percent, to $8.90.
Allergan fell$. 08 or. 1 percent, to $103.78. Baxter International Inc. rose$. 03 or percent, to $70.49. Boston Scientific Corp. rose$. 05 or. 6 percent, to $8.70.
Baxter International Inc. rose$. 39 or. 6 percent, to $70.85. Boston Scientific Corp. fell$. 02 or. 2 percent, to $8.63. Johnson& Johnson rose$. 84 or 1.0 percent, to $86.69.
Allergan fell$. 36 or. 3 percent, to $103.50. Baxter International Inc. rose$. 33 or. 5 percent, to $70.79. Boston Scientific Corp. rose$. 01 or. 1 percent, to $8.66.
Allergan fell$. 32 or. 3 percent, to $103.86. Baxter International Inc. fell$. 30 or. 4 percent, to $70.46. Boston Scientific Corp. rose$. 20 or 2.4 percent, to $8.65.
Allergan fell$. 18 or. 2 percent, to $104.00. Baxter International Inc. fell$. 03 or percent, to $70.74. Boston Scientific Corp. rose$. 29 or 3.4 percent, to $8.74.
Allergan fell$. 37 or. 4 percent, to $103.82. Baxter International Inc. fell$. 34 or. 5 percent, to $70.42. Medtronic fell$. 02 or percent, to $49.15.
April 30- St. Jude Medical Inc:. *Announces ce mark and launch of first quadripolar crt pacemaker. *Says the allure quadra crt-p device is currently not approved for use in the.
April 26- St. James's Place:. *Numis raises target price to 610 p from 580 p; rating add. Reuters Station users, click. 1580 (; ().
LONDON, April 25- St. James's Place PLC:. *Total new business on an annual premium equivalent basis of 199.2. *Net inflow of funds under management of 947 million.
In the U.S. volumes at hospitals, in-patient and out-patient are soft, "said David Heupel, senior healthcare analyst at Thrivent Investment Management.
April 17- Medical device maker St. Jude Medical Inc said on Wednesday its quarterly earnings rose as expenses fell. First-quarter net earnings were $222 million, or 78 cents per diluted share, compared with $212 million, or 67 cents per diluted share, in the year ago period.
First-quarter net earnings were $222 million, or 78 cents per diluted share, compared with $212 million, or 67 cents per diluted share, in the year ago period.
April 17- Medical device maker St. Jude Medical Inc said on Wednesday first-quarter profit rose as lower expenses outweighed a decline in sales but warned that full-year revenue will be hurt by foreign exchange effects.
LONDON, April 10- GlaxoSmithKline, Britain's biggest drugmaker, is placing a small but important bet on a new way of treating diseases by targeting electrical signals in the body.
April 10- St. Jude Medical Inc said on Wednesday it received European regulatory approval for a brain implant used to treat primary and secondary Dystonia, a neurological movement disorder.